XyloCor Therapeutics
XyloCor Therapeutics is focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy.
2
Funding Rounds
$58.9m
Money raised
Overview
XyloCor Therapeutics is focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company XyloCor Therapeutics has raised a total of $41.9m in funding over 2 rounds.
Key Insights:
- XyloCor Therapeutics , March 2021: $41.9m
- XyloCor Therapeutics funding round, December 2018: $17m
XyloCor Therapeutics , March 2021
$41.9m
XyloCor Therapeutics funding round, December 2018
$17m
Industries
XyloCor Therapeutics is active in the following industries: